Chih-shin Chang
TPQ 11529, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody.
Journal: JCI insight
Published: January 24, 2024
Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission.
Journal: Journal of biomedical science
Published: May 15, 2023
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 04, 2023
Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva.
Journal: Microbiology spectrum
Published: April 25, 2023
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.
Journal: Emerging microbes & infections
Published: November 17, 2022
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: August 01, 2022
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.
Journal: Journal of biomedical science
Published: April 20, 2022
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan.
Journal: Vaccines
Published: January 17, 2022
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.
Journal: The Lancet. Respiratory medicine
Published: July 28, 2021
Novel Naturally Occurring Mutations of Enterovirus 71 Associated With Disease Severity.
Journal: Frontiers in microbiology
Published: September 26, 2020
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model.
Journal: Journal of biomedical science
Published: August 06, 2019
Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model.
Journal: Scientific reports
Published: March 18, 2019
Last Updated: 09/26/2026